Extends federal authorization for tick and vector-borne disease programs through 2030, including the national strategy, regional research centers, and state and local health department support.

Official title: To reauthorize the Kay Hagan Tick Act, and for other purposes.

Next stop Senate: awaiting action

Timeline each lane is a chamber; dates pull from congress.gov actions

House

Introduced 10-JUL-2025

Referred 10-JUL-2025

Approved by committee 21-MAY-2026

Reported 02-JUL-2026

On the calendar 02-JUL-2026

Passed 20-JUL-2026

Senate

Received 21-JUL-2026

Key points

Changes the authorization period for the national vector-borne disease strategy and regional centers of excellence from 2021 through 2025 to 2026 through 2030.
Replaces the reference to the Tick-Borne Disease Working Group and other individuals with "appropriate individuals" in the strategy provision.
Adds increasing capacity to identify, report, prevent, and respond to vector-borne diseases to the strategy's purposes.
Extends the enhanced support program that helps health departments address vector-borne diseases for 2026 through 2030.

AI-generated from the Placed on Calendar Senate text of 21-JUL-2026 · verify · report an error

Official CRS summary

Covers an older version. The newest CRS summary describes the bill as of "Reported to House" (02-JUL-2026); the text has changed since (Engrossed in House, 20-JUL-2026).

CRS is the Library of Congress's nonpartisan research office. Read it on congress.gov

Committee referrals (2)

Energy and Commerce Committee (House)
Health Subcommittee

Policy area

Health

Sponsor Christopher H. Smith (R-NJ) Cosponsors · 36

■ 28 D■ 8 R

28 Democrats

Show all 28 Democrats

8 Republicans

congress.gov page Placed on Calendar Senate (21-JUL-2026) Engrossed in House (20-JUL-2026) Reported in House (02-JUL-2026) Introduced in House (10-JUL-2025)